24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Shipley graduated the medical school from the Marshall University Joan C. Edwards. She did her internship at the Allegheny General Hospital-Western Pennsylvania Hospital and completed her residency program at the Charleston Area Medical Center. A fellowship followed at the Wake Forest University soon after that. She is specialized in Medical Oncology and board certified in Oncology. Dr. Shipley has been in practice for more than 20 years and is affiliated with the TriStar Centennial Medical Center. During her career, she has also contributed to various publications of medical interest.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHumanaMultiPlan
Marshall University Joan C. Edwards
Medical School
Allegheny General Hospital - Western Pennsylvania Hospital
Internship
Charleston Area Medical Center
Residency
Wake Forest University
Fellowship
American Board of Internal Medicine - Oncology
TriStar Centennial Medical Center
Languages: English/Spanish
(615) 342-1000
2300 Patterson St
Nashville, Tennessee 37203 
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Yardley DA, Shipley DL, Peacock NW, Shastry M, Midha R, Priego VM, Hainsworth JD; Breast Cancer Res. Treat.. 2015-08-01
See more >>
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium.
Hainsworth, J. D.,Shipley, D. L.,Reeves, J.,Arrowsmith, E. R.,Barnes, E. K.,Waterhouse, D. M.; Clin Genitourin Cancer. 2013 Sep.
See more >>
11 citations Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
Hainsworth, J. D.,Waterhouse, D. M.,Penley, W. C.,Shipley, D. L.,Thompson, D. S.,Webb, C. D.,Anthony Greco, F.; Cancer Invest.. 2013 Jun.
See more >>